Etid klinik pou Krèz nan Florid
16 etid pou Krèz ap chèche patisipan nan sit nan Florid.
Vil nan Florid
Tèks ofisyèl etid la (Anglè)
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Northwest Florida Clinical Research Group, LLC, Gulf Breeze
- Ilumina Medical Research, Kissimmee
- Visionary Investigators Network, Miami
- ak 3 plis
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Oct 1, 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Panhandle Research and Medical Clinic, LLC, Gulf Breeze
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07563881Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
- Mayo Clinic, Jacksonville
Ap rekriteFaz 1 bonèMande peman pou patisipan yo
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07012148Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- University of Florida, Gainesville
Ap rekrite
Jiska laj 50 · Tout sèks · Mizajou Sep 17, 2026 · NCT02216500A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Pediatric Neurology and Epilepsy Specialists, Winter Park
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04462770An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- University of Miami Miller School of Medicine, Miami
- AdventHealth Innovation Tower, Orlando
Ap rekriteFaz 3
Laj 2 a 55 · Tout sèks · Mizajou Sep 15, 2026 · NCT05066217Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- K2 Medical Research, Maitland
- Serenity Research Center, LLC, Miami
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07594119A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- University of South Florida, Tampa
Ap rekriteFaz 1
Laj 12 a 75 · Tout sèks · Mizajou Aug 11, 2026 · NCT07233239Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Miami, Miami
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Jun 9, 2026 · NCT05135091AI-Based Mobile Intervention on Medication Non-Adherence and Transition
- Orlando Health Arnold Palmer Hospital, Orlando
- Orlando Health Orlando Regional Medical Center, Orlando
Ap rekrite
Laj 14 a 24 · Tout sèks · Mizajou May 29, 2026 · NCT07445074A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Panhandle Research and Medical Clinic, Gulf Breeze
- Mayo Clinic Florida, Jacksonville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT05716100Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
- Green Leaf Clinical Trials, LLC, Jacksonville
- Visionary Investigators Network, Miami
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Apr 21, 2026 · NCT05518578Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- Miami VA Healthcare System, Miami, FL, Miami
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT04419272SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
- Medsol Clinical Research Center, Port Charlotte
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 10, 2025 · NCT07141329Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Pediatric Epilepsy and Neurology Specialists, Tampa
Ap rekriteFaz 3
Laj 4 a 55 · Tout sèks · Mizajou Jul 24, 2025 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Miami Lakes
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 3, 2025 · NCT06908356Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.